
Jerry M. Blevins
Examiner (ID: 11930, Phone: (571)272-8581 , Office: P/2883 )
| Most Active Art Unit | 2883 |
| Art Unit(s) | 2883, 2874 |
| Total Applications | 1547 |
| Issued Applications | 1283 |
| Pending Applications | 101 |
| Abandoned Applications | 184 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20068584
[patent_doc_number] => 20250206806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => POLYNUCLEOTIDES ENCODING APOA-1 FUSION POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 19/074055
[patent_app_country] => US
[patent_app_date] => 2025-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19074055
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/074055 | Polynucleotides encoding APOA-1 fusion polypeptides | Mar 6, 2025 | Issued |
Array
(
[id] => 20059613
[patent_doc_number] => 20250197835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/071264
[patent_app_country] => US
[patent_app_date] => 2025-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19071264
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/071264 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Mar 4, 2025 | Pending |
Array
(
[id] => 20033539
[patent_doc_number] => 20250171761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => NOVEL RECOMBINANT FACTOR C AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR MEASURING ENDOTOXIN
[patent_app_type] => utility
[patent_app_number] => 19/048328
[patent_app_country] => US
[patent_app_date] => 2025-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19048328
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/048328 | NOVEL RECOMBINANT FACTOR C AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR MEASURING ENDOTOXIN | Feb 6, 2025 | Pending |
Array
(
[id] => 20033538
[patent_doc_number] => 20250171760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => NOVEL RECOMBINANT FACTOR C AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR MEASURING ENDOTOXIN
[patent_app_type] => utility
[patent_app_number] => 19/048080
[patent_app_country] => US
[patent_app_date] => 2025-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19048080
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/048080 | NOVEL RECOMBINANT FACTOR C AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR MEASURING ENDOTOXIN | Feb 6, 2025 | Abandoned |
Array
(
[id] => 20033537
[patent_doc_number] => 20250171759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => NOVEL RECOMBINANT FACTOR C AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR MEASURING ENDOTOXIN
[patent_app_type] => utility
[patent_app_number] => 19/041627
[patent_app_country] => US
[patent_app_date] => 2025-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19041627
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/041627 | NOVEL RECOMBINANT FACTOR C AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR MEASURING ENDOTOXIN | Jan 29, 2025 | Pending |
Array
(
[id] => 20120484
[patent_doc_number] => 20250235515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES
[patent_app_type] => utility
[patent_app_number] => 19/029923
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19029923
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/029923 | CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES | Jan 16, 2025 | Pending |
Array
(
[id] => 19998427
[patent_doc_number] => 20250136649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => HONEY TRUFFLE SWEETENER (HTS) VARIANTS
[patent_app_type] => utility
[patent_app_number] => 19/003764
[patent_app_country] => US
[patent_app_date] => 2024-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19003764
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/003764 | HONEY TRUFFLE SWEETENER (HTS) VARIANTS | Dec 26, 2024 | Abandoned |
Array
(
[id] => 19862614
[patent_doc_number] => 20250101400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/965675
[patent_app_country] => US
[patent_app_date] => 2024-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 202820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18965675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/965675 | CRISPR enzymes and systems | Dec 1, 2024 | Issued |
Array
(
[id] => 20050185
[patent_doc_number] => 20250188407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => PHYLLOBACTERIUM MYRSINACEARUM STRAIN N1N2-2 FOR EFFICIENT DEGRADATION OF DIPHENYLARSINIC ACID AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/926774
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926774
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/926774 | None | Oct 24, 2024 | Issued |
Array
(
[id] => 19770318
[patent_doc_number] => 20250051744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/893331
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893331 | POLYPEPTIDES | Sep 22, 2024 | Pending |
Array
(
[id] => 20050288
[patent_doc_number] => 20250188510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => ENHANCEMENT OF KINASE TARGET ENGAGEMENT
[patent_app_type] => utility
[patent_app_number] => 18/812371
[patent_app_country] => US
[patent_app_date] => 2024-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18812371
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/812371 | ENHANCEMENT OF KINASE TARGET ENGAGEMENT | Aug 21, 2024 | Pending |
Array
(
[id] => 20795707
[patent_doc_number] => 20260176606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-06-25
[patent_title] => PROTEIN WITH XYLANASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/833521
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18833521
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/833521 | PROTEIN WITH XYLANASE ACTIVITY | Jul 25, 2024 | Pending |
Array
(
[id] => 19479848
[patent_doc_number] => 20240327890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => MODULATION OF CELL GROWTH AND GLYCOSYLATION IN RECOMBINANT GLYCOPROTEIN PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/741057
[patent_app_country] => US
[patent_app_date] => 2024-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18741057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/741057 | MODULATION OF CELL GROWTH AND GLYCOSYLATION IN RECOMBINANT GLYCOPROTEIN PRODUCTION | Jun 11, 2024 | Pending |
Array
(
[id] => 19418730
[patent_doc_number] => 20240294853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => Mannanase Variants and Polynucleotides Encoding Same
[patent_app_type] => utility
[patent_app_number] => 18/666610
[patent_app_country] => US
[patent_app_date] => 2024-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18666610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/666610 | Mannanase variants and polynucleotides encoding same | May 15, 2024 | Issued |
Array
(
[id] => 19847084
[patent_doc_number] => 20250092435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => METHODS OF MAKING CHITOSAN
[patent_app_type] => utility
[patent_app_number] => 18/601266
[patent_app_country] => US
[patent_app_date] => 2024-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18601266
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/601266 | Methods of making chitosan | Mar 10, 2024 | Issued |
Array
(
[id] => 19172793
[patent_doc_number] => 20240158767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => POLYMERASE ENZYME FROM PHAGE T4
[patent_app_type] => utility
[patent_app_number] => 18/416306
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18416306
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/416306 | POLYMERASE ENZYME FROM PHAGE T4 | Jan 17, 2024 | Abandoned |
Array
(
[id] => 19098156
[patent_doc_number] => 20240117384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHOD FOR CONVERTING NUCLEIC ACID SEQUENCE OF CELL SPECIFICALLY CONVERTING NUCLEIC ACID BASE OF TARGETED DNA USING CELL ENDOGENOUS DNA MODIFYING ENZYME, AND MOLECULAR COMPLEX USED THEREIN
[patent_app_type] => utility
[patent_app_number] => 18/539833
[patent_app_country] => US
[patent_app_date] => 2023-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18539833
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/539833 | METHOD FOR CONVERTING NUCLEIC ACID SEQUENCE OF CELL SPECIFICALLY CONVERTING NUCLEIC ACID BASE OF TARGETED DNA USING CELL ENDOGENOUS DNA MODIFYING ENZYME, AND MOLECULAR COMPLEX USED THEREIN | Dec 13, 2023 | Pending |
Array
(
[id] => 19318619
[patent_doc_number] => 20240240162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => ENGINEERED POLYMERASES FOR IMPROVED SEQUENCING BY BINDING
[patent_app_type] => utility
[patent_app_number] => 18/515603
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515603
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/515603 | Engineered polymerases for improved sequencing by binding | Nov 20, 2023 | Issued |
Array
(
[id] => 19067191
[patent_doc_number] => 20240101617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => TARDIGRADE DISORDERED PROTEINS AS PROTEIN STABILIZERS
[patent_app_type] => utility
[patent_app_number] => 18/513744
[patent_app_country] => US
[patent_app_date] => 2023-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513744 | TARDIGRADE DISORDERED PROTEINS AS PROTEIN STABILIZERS | Nov 19, 2023 | Abandoned |
Array
(
[id] => 20007690
[patent_doc_number] => 20250145912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => DETERGENT COMPOSITIONS CONTAINING A XYLOGLUCANASE AND A HUEING DYE
[patent_app_type] => utility
[patent_app_number] => 18/501324
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501324
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501324 | DETERGENT COMPOSITIONS CONTAINING A XYLOGLUCANASE AND A HUEING DYE | Nov 2, 2023 | Pending |